FeaturedNews LUMC & Batavia Biosciences Burst the Bubble Severe Combined Immunodeficiency (SCID) disease affects 1 in 35,000 newborns annually, of which approximately 145…Aaron Ogdahl29 November 2022
News Eize De Boer featured as prominent speaker at ATMP-themed TechTalks Eize De Boer showed us what it takes to realize a new facility for Batavia Biosciences designed for…Aaron Ogdahl28 October 2022
News Batavia Biosciences Optimizes Global Quality Assurance with Veeva Vault Quality Suite BARCELONA, Spain — September 15, 2022- Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected…Aaron Ogdahl15 September 2022
News Batavia manufactures LASV vaccine candidate for IAVI who today announced the first vaccinations of their Lassa fever vaccine candidate Batavia Biosciences would like to congratulate IAVI on their press release, as today they've announced volunteers…Aaron Ogdahl31 August 2022
FeaturedNews Batavia enters the commercial manufacturing business Leiden, The Netherlands, June 28, 2022 – Today, Batavia Biosciences announces that it will extend…Aaron Ogdahl28 June 2022
News Batavia produces lentivirus for first patient in the Netherlands successfully treated with stem cell gene therapy It is with great enthusiasm and excitement that we would like to congratulate Leiden University Medical…Aaron Ogdahl27 June 2022
News Batavia Biosciences increases capacity for viral vectors and vaccine R&D in Netherlands. Leiden, The Netherlands, June 14, 2022 – Today, Batavia Biosciences announces the expansion of its…Aaron Ogdahl14 June 2022
FeaturedNews Batavia wins 2022 ViE Award for Best Process Development Washington, April 20, 2022 - Batavia Biosciences was honored this week during the Vaccine Industry…Claire Otjes20 April 2022
News Batavia Biosciences appoints Ron van Eijsden, Ph.D., as Head of Business Development With Ron van Eijsden heading the Sales and Business Development team, Batavia expands its Management…Aaron Ogdahl12 April 2022
News Batavia Biosciences joins the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Woburn, MA, USA, March 22, 2022 -- Batavia Biosciences Inc. announces today that it has…Aaron Ogdahl22 March 2022